Jump to content
Powered by


The latest articles, press releases and dossiers on pharmaceutics in Baden-Württemberg

  • Article - 18/05/2015

    Parvoviruses such as H-1PV have been shown to selectively attack and destroy human cancer cells. However, they are unable to replicate in healthy human cells. A preliminary clinical trial is currently being carried out to assess the suitability of parvoviruses for treating malignant brain cancer. Scientists from the German Cancer Research Center (DKFZ) have now discovered the cause of the selective effect of H-1PV. The finding helps identify…

  • Article - 11/05/2015

    Fungal infections of skin and mucous membranes are relatively common. Around 75 percent of the human population lives with Candida albicans, a fungus that has no harmful effects in people with an intact immune system that can fight off systemic infections. However, in people with immune systems that have been weakened by antibiotics or radiotherapy for example C. albicans infections can lead to sepsis which may even be life-threatening. Prof. Dr.…

  • Article - 04/05/2015

    For graduates with innovative business ideas, becoming independent entrepreneurs can be an interesting alternative to traditional career paths. This is exactly what Dr. Reinhold Horlacher thought 15 years ago. He had just been awarded his PhD from the University of Konstanz, and had a business idea that he decided to turn into reality by establishing a company called Trenzyme GmbH. In the following interview with BIOPRO, he describes his…

  • Article - 27/04/2015

    Professor Martin Wabitsch from Ulm University Hospital has been studying the genetic causes of obesity for quite some time. The discovery of another cause of this complex condition that has key clinical consequences was recently published in the renowned New England Journal of Medicine. Despite the internationally acknowledged success of this research and in contrast to the view of the World Health Organisation and scientific organisations, the…

  • Article - 22/04/2015

    AIDS-causing HI viruses preferentially integrate into transcriptionally active genes of the host cell genome. These gene regions are located in the immediate vicinity of the nuclear pores. A team of researchers from Heidelberg University Hospital and colleagues from Italy have now shown that the integration of the viruses is controlled by components of the nuclear pores. These findings are an important step towards gaining a detailed…

  • Dossier - 13/04/2015

    The activation of the body’s immune system to fight cancer is not only a promising therapeutic concept, but is already used in medical practice. The first immunotherapies have been approved and many more are either in the experimental stages or already undergoing clinical testing. Vaccines to prevent certain types of cancer are already being used successfully around the world.

  • Press release - 01/04/2015

    The slow death of dopamine-producing nerve cells in a certain region of the brain is the principal cause underlying Parkinson's disease. In mice, it is possible to simulate the symptoms of this disease using a substance that selectively kills dopamine-producing neurons. Scientists from the German Cancer Research Center (DKFZ) have now shown for the first time in mouse experiments that after this treatment, cells of the peripheral immune…

  • Article - 30/03/2015

    Too much stress makes you sick – this is the widely held opinion. But exactly how chronic psychological stress affects our body is not yet fully understood. This is the question Dr. Annette Sommershof and her team from the University of Konstanz are trying to answer. The scientists are exploring stress-related changes in the immune system and have found evidence for the observation that long-term stress weakens the immune system, resulting in…

  • Article - 23/03/2015

    Crowdfunding has become a popular widely-talked-about financing tool that opens up new ways of acquiring money for projects that might not otherwise receive backing. The financing model is based on the simple idea of raising many small amounts of capital to finance a large project. In early 2015 a company called Riboxx secured the capital it needed through a campaign on the Seedmatch crowdfunding platform. The German company aescuvest GmbH…

  • Article - 23/03/2015

    cytena GmbH, a start-up company which was spun out from the Department of Microscystems Engineering (IMTEK) at the University of Freiburg in 2014, has developed a device that enables single cells to be deposited safely and gently using a single-cell printer called cy-Clone. Once processed, the cells can be used to study tumour heterogeneity and to create clonal cell lines for producing antibodies.

  • Press release - 19/03/2015

    The new RNA Bioinformatics Center (RBC) is a joint project of the Universities of Freiburg and Leipzig as well as the Max-Delbrück Center Berlin. It is one of six performance centers selected for funding by the Federal Ministry of Education and Research (BMBF) and will receive 3.3 million euros in the next five years. It is part of the project “German Network for Bioinformatics Infrastructure,” which was launched on 1 March 2015.

  • Article - 16/03/2015

    Microbial metabolic products can be used in the fight against dangerous pathogens such as multidrug-resistant bacteria. Since summer 2014, microbiologist Prof. Dr. Heike Brötz-Oesterhelt has been investigating the mechanisms of action of bacterial substances at the University of Tübingen with the aim of paving the way for new antibiotics. Interesting candidates have already been identified.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/pharma